Cargando…
Gp-100 as a Novel Therapeutic Target in Uveal Melanoma
SIMPLE SUMMARY: Glycoprotein 100 (Gp-100) is a protein highly expressed in melanoma tissue that has recently been effectively targeted by tebentafusp, a first-in-class bispecific protein of the immune-mobilizing monoclonal T cell receptors against cancer (ImmTACs) family. Recently, a randomized phas...
Autores principales: | Martinez-Perez, Daniel, Viñal, David, Solares, Isabel, Espinosa, Enrique, Feliu, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656894/ https://www.ncbi.nlm.nih.gov/pubmed/34885078 http://dx.doi.org/10.3390/cancers13235968 |
Ejemplares similares
-
High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
por: de Vries, T. J., et al.
Publicado: (1998) -
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review
por: Solares, I., et al.
Publicado: (2021) -
S100 as Serum Tumor Marker in Advanced Uveal Melanoma
por: Salzmann, Martin, et al.
Publicado: (2023) -
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
por: Basile, Maria Sofia, et al.
Publicado: (2019) -
Targeting Epigenetic Modifications in Uveal Melanoma
por: Chokhachi Baradaran, Pooneh, et al.
Publicado: (2020)